Oncologie-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-03-14 ms4000001968180923 来自山西省

审稿速度:1.0 | 投稿命中率:75.0
经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨

18 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-06-27 投必中来自湖北省

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。

40 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-02-07 ms6000001061179330 来自上海

你

22 0

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-10-29 ms6000000065827164 来自江苏省

请问一下状态显示Under Review是到哪一步了，内审还是外审？

26 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-10-04 ms9000001319121042 来自河南省

审稿速度:1.0
经验分享：2

31 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-06-09 147170_6998

有没有lncRNA临床诊断方面文章好投的水刊呀

41 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-08-23 ms5000000008879620

投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊

63 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-08-05 ms4000000960541522

这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投

59 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

实验大概做到什么阶段动手写文章比较合适？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2193267, encodeId=bbec219326ee4, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：期刊审稿速度挺快的，一个多月就接收了，审稿人意见很专业，希望影响因子再涨涨, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63b08347995, createdName=ms4000001968180923, createdTime=Thu Mar 14 20:31:31 CST 2024, time=2024-03-14, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2145101, encodeId=453e2145101ce, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：22.10.31投稿，11.30收到外审意见，小修，给了两周时间修改，编辑人很好，如果觉得时间不够可以申请再长一点的时间。12.20返修回去，12.29被接受。2023.1.3交版面费一千欧元，2.14online，4.6号检索。总体来说还是很快的，虽然是四区，IF也不高，但解决了毕业的难题。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221106/5f7f95357a3d4a089ac253c47ce0eeaf/94a8b931e92e418795495b47d393083d.jpg, createdBy=8bbc8321893, createdName=投必中, createdTime=Tue Jun 27 22:44:52 CST 2023, time=2023-06-27, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2186321, encodeId=6b9e218632184, content=你, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17519130733, createdName=ms6000001061179330, createdTime=Wed Feb 07 10:24:10 CST 2024, time=2024-02-07, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2165596, encodeId=20ca216559625, content=请问一下状态显示Under Review是到哪一步了，内审还是外审？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=26, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b3248853623, createdName=ms6000000065827164, createdTime=Sun Oct 29 21:02:02 CST 2023, time=2023-10-29, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2160960, encodeId=033521609600f, content=审稿速度:1.0 经验分享：2, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a408858079, createdName=ms9000001319121042, createdTime=Wed Oct 04 22:51:53 CST 2023, time=2023-10-04, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1225389, encodeId=908f12253895d, content=有没有lncRNA临床诊断方面文章好投的水刊呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=41, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787a6278540, createdName=147170_6998, createdTime=Thu Jun 09 10:32:48 CST 2022, time=2022-06-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010737, encodeId=0f261010e3773, content=投稿一天后就看到显示declined，我还点了declined是怎么回事，是被拒稿了，还是我点错了啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f9e45504733, createdName=ms5000000008879620, createdTime=Mon Aug 23 21:24:24 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005366, encodeId=a047100536645, content=这个期刊改成OA了，发表英文稿，影响影子涨了不少，挺有潜力的，可以投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa325564691, createdName=ms4000000960541522, createdTime=Thu Aug 05 14:39:33 CST 2021, time=2021-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102617, encodeId=5725110261e20, content=实验大概做到什么阶段动手写文章比较合适？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1102618, encodeId=a28f110261848, content=researcharticle一般写作顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 ms6000000264964247

researcharticle一般写作顺序是什么？

52 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务